Arkadios Wealth Advisors’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$259K Buy
12,600
+11
+0.1% +$252 ﹤0.01% 1487
2026
Q1
$277K Sell
12,589
-479
-4% -$8.34K ﹤0.01% 1398
2025
Q4
$154K Sell
13,068
-4,449
-25% -$57.1K ﹤0.01% 1477
2025
Q3
$277K Buy
+17,517
New +$254K 0.01% 1188
2021
Q4
Sell
-1,022
Closed -$29K 757
2021
Q3
$29K Sell
1,022
-418
-29% -$13.5K ﹤0.01% 1074
2021
Q2
$50K Buy
1,440
+418
+41% +$13.8K 0.01% 924
2021
Q1
$28K Hold
1,022
﹤0.01% 865
2020
Q4
$25K Buy
+1,022
New +$24.3K 0.01% 695

Other funds holding CC

Arkadios Wealth Advisors's CC Position: Q2 2026 in Review

Arkadios Wealth Advisors increased its Chemours (CC) stake by 0.09% in Q2 2026, buying an estimated $252 and bringing the position to 12,600 shares worth $259K. The position accounts for ﹤0.01% of the portfolio, ranked #1487.

Arkadios Wealth Advisors first reported a position in CC in Q4 2020 and has held it in 8 quarters since. The position peaked at $277K in Q3 2025. 473 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Arkadios Wealth Advisors held 12,600 shares of Chemours worth $259K as of Q2 2026.
  • Arkadios Wealth Advisors bought 11 Chemours shares in Q2 2026, an estimated $252.
  • Chemours made up ﹤0.01% of Arkadios Wealth Advisors's portfolio in Q2 2026, its #1487 holding.
  • Arkadios Wealth Advisors first reported a position in Chemours in Q4 2020 and has held it in 8 quarters since.
  • Arkadios Wealth Advisors's Chemours position peaked at $277K in Q3 2025.
  • 473 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Arkadios Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.